PT-141 – 10mg
Intended strictly for research purposes only.
This research compound is provided in lyophilized form and packaged in a 3ml vial to ensure stability and reliable handling. PT-141 is prepared for research settings that require precise materials for controlled studies.
Supplied as lyophilized powder for extended stability
Packaged in a 3ml vial
Suitable for a variety of laboratory research studies
This product requires reconstitution.
PT-141, known generically as bremelanotide, is a synthetic peptide that stimulates melanocortin receptors in the brain to increase sexual desire and arousal. It is FDA-approved under the brand name Vyleesi as an injectable treatment for hypoactive sexual desire disorder in premenopausal women. [1, 2]
How It Works
- Difference from ED Meds: Unlike sildenafil (Viagra), which works peripherally on blood vessels, PT-141 works centrally through the nervous system to generate desire. [1]
Uses and Administration
- Approved Use: Prescribed for premenopausal women with generalized, acquired low sexual desire causing personal distress.
- Off-Label/Research Use: Sometimes utilized or studied off-label for men dealing with erectile dysfunction or low libido, especially when standard PDE5 inhibitors fail.
Side Effects and Risks
- Common Reactions: Nausea (the most frequent side effect), flushing, headache, and injection-site reactions. [1]
- Cardiovascular Note: Can cause a temporary increase in blood pressure and decrease in heart rate; it is not advised for individuals with uncontrolled high blood pressure or cardiovascular disease. [1]















Reviews
There are no reviews yet.